Julie Krop's Net Worth
$443 Thousand
Who is Julie Krop?
Julie Krop does not have any significant net worth to report based on the numbers we have. This is based on reported shares across multiple companies, which include AMAG PHARMACEUTICALS, INC., and Aquestive Therapeutics, Inc..
SEC CIK
Julie Krop's CIK is 0001643127
Past Insider Trading and Trends
2019 was Julie Krop's most active year for acquiring shares with 4 total transactions. Julie Krop's most active month to acquire stocks was the month of January. 2017 was Julie Krop's most active year for disposing of shares, totalling 4 transactions. Julie Krop's most active month to dispose stocks was the month of February. 2019 saw Julie Krop paying a total of $99,100.00 for 60,000 shares, this is the most they've acquired in one year. In 2016 Julie Krop cashed out on 7,332 shares for a total of $175,441.62, their largest year based on trade value.
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
AMAG PHARMACEUTICALS, INC. No price found
Chief Medical Officer
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
| -1.79% | -1.33K |
$7.75 | -$10,330.75 | 73.04K |
Mar 2
| |||
Form 4
| -2.41% | -2.02K |
$9.12 | -$18,446.70 | 81.88K |
Feb 23 - Feb 25
| |||
Form 4
| +14.01% | 10K |
$9.91 | $99,100.00 | 81.4K |
May 28
| |||
Form 4
| -3.00% | -2.21K |
$14.76 | -$32,575.32 | 71.4K |
Mar 1 - Mar 2
| |||
Form 4
| +51.43% | 25K |
—
|
—
| 73.61K |
Feb 25
| |||
Form 4
| -1.76% | -869.00 |
$15.51 | -$13,478.19 | 48.61K |
Feb 23
| |||
Form 4
| -4.19% | -2.16K |
$19.85 | -$42,895.85 | 49.48K |
Jul 2
| |||
Form 4
| +82.23% | 23.3K |
$21.00 | -$35,700.00 | 51.64K |
Mar 2
| |||
Form 4
| -14.84% | -4.94K |
$20.00 | -$98,760.00 | 28.34K |
Scheduled
|
Jul 13
| ||
Form 4
| -9.52% | -3.50K |
$19.47 | -$68,188.30 | 33.27K |
Mar 1 - Jun 1
| |||
Form 4
| -4.89% | -1.89K |
$24.45 | -$46,234.95 | 36.78K |
Scheduled
|
May 1
| ||
Form 4
| +63.38% | 15K |
—
|
—
| 38.67K |
Feb 23
| |||
Form 4
| -17.26% | -4.94K |
$24.80 | -$122,462.40 | 23.67K |
Scheduled
|
Oct 20
| ||
Form 4
| -7.72% | -2.39K |
$22.13 | -$52,979.22 | 28.61K |
Jun 1
| |||
Form 4
| +40.91% | 9K |
—
|
—
| 31K |
Mar 1
| |||
Form 4
|
∞
| 22K |
—
|
—
| 22K |
Jun 1
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||
Aquestive Therapeutics, Inc. (AQST) Snapshot price: $2.65
Investor
Form Type
|
Δ Own
|
Qty.
|
Price
|
Size ($)
|
Own
|
Filing Date
|
Type
|
Is Scheduled
|
Trade Dates
|
|---|---|---|---|---|---|---|---|---|---|
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 21
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 22
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Jun 15
| |||
Form 4
|
—
|
0
|
—
|
—
|
0
|
Mar 11
| |||
Form 3
|
—
|
0
|
—
|
—
|
0
| ||||
| No matching records found | |||||||||